title: Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.
abstract: The biological nature of Spitz nevi/tumors and their diagnostic distinction from, or relationship to, melanoma remain unresolved issues. In this report, a series of 30 melanocytic lesions removed from 28 patients, including atypical Spitz nevi/tumors and metastasizing Spitzoid tumors/melanomas, were evaluated by a panel of dermatopathologists to evaluate interobserver diagnostic concordance and to assess the prognostic power of histological criteria. For inclusion in the study, each lesion had to display some criteria for the Spitz nevus, and in addition one of the following was required: (1) definitive clinical outcome such as metastasis or death of disease, or (2) long-term follow-up if the patient remained disease free. Each lesion was reviewed independently and blinded as to the clinical data by 10 pathologists, who categorized them as (1) typical Spitz nevus/tumor, (2) atypical Spitz nevus/tumor, (3) melanoma, (4) tumor with unknown biological potential, or (5) other melanocytic lesion. There was limited discussion of criteria before the review. Evaluation of 17 Spitzoid lesions yielded no clear consensus as to diagnosis; in only one case did six or more pathologists agree on a single category, regardless of clinical outcome. Notably, however, some lesions that proved fatal were categorized by most observers as either Spitz nevi or atypical Spitz tumors. Conversely, seven or more pathologists scored 13 lesions as melanoma. These results illustrate (1) substantial diagnostic difficulties posed by many Spitz tumors, especially those with atypical features, even among experts, and (2) the lack of objective criteria for their distinction from melanoma and for gauging their malignant potential. Nevertheless, our observations do suggest that a biological relationship exists between the Spitz nevus/tumor and melanoma.
authors.affiliation: Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
authors.forename: R L
authors.initials: RL
authors.lastname: Barnhill
authors.forename: Z B
authors.initials: ZB
authors.lastname: Argenyi
authors.forename: L
authors.initials: L
authors.lastname: From
authors.forename: L F
authors.initials: LF
authors.lastname: Glass
authors.forename: J C
authors.initials: JC
authors.lastname: Maize
authors.forename: M C
authors.initials: MC
authors.lastname: Mihm
authors.forename: M S
authors.initials: MS
authors.lastname: Rabkin
authors.forename: S G
authors.initials: SG
authors.lastname: Ronan
authors.forename: W L
authors.initials: WL
authors.lastname: White
authors.forename: M
authors.initials: M
authors.lastname: Piepkorn
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000175:diagnosis / Q000473:pathology*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D018332:Nevus, Epithelioid and Spindle Cell / Q000175:diagnosis / Q000473:pathology*; D015588:Observer Variation; D011379:Prognosis; D012878:Skin Neoplasms / Q000175:diagnosis / Q000473:pathology*